1. Home
  2. OFIX vs IVVD Comparison

OFIX vs IVVD Comparison

Compare OFIX & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$15.15

Market Cap

622.1M

Sector

Health Care

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.45

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
IVVD
Founded
1987
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.1M
692.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OFIX
IVVD
Price
$15.15
$2.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$21.50
$8.75
AVG Volume (30 Days)
190.2K
4.8M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$818,058,000.00
$50,039,000.00
Revenue This Year
$3.97
$103.88
Revenue Next Year
$5.84
$171.40
P/E Ratio
N/A
N/A
Revenue Growth
4.31
332.71
52 Week Low
$10.24
$0.35
52 Week High
$20.48
$3.07

Technical Indicators

Market Signals
Indicator
OFIX
IVVD
Relative Strength Index (RSI) 45.02 50.81
Support Level $14.88 $2.52
Resistance Level $16.00 $2.85
Average True Range (ATR) 0.45 0.20
MACD -0.05 -0.02
Stochastic Oscillator 25.82 29.52

Price Performance

Historical Comparison
OFIX
IVVD

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: